StockData
Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc. (VKTX) stock

VKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/30
$26.17−0.71 (-2.64%)

Close on Nov 18, 2026Market cap $3.34BP/E –Yield –

Viking Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Viking Therapeutics's market cap was $3.32B on Nov 11, 2026, against $4.14B a year earlier. Over the last 5 years it ranged from $171.77M to $8.21B, with a median of $3.04B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.32B-16.1%
2025Dec 31, 2025$3.96B-11.8%
2024Dec 31, 2024$4.48B+140.9%
2023Dec 29, 2023$1.86B+158.2%
2022Dec 30, 2022$720.87M+100.3%
2021Dec 31, 2021$359.88M-12.3%
2020Dec 31, 2020$410.55M-29.2%
2019Dec 31, 2019$579.49M+6.3%
2018Dec 31, 2018$545.33M+371.3%
2017Dec 29, 2017$115.71M+388.7%
2016Dec 30, 2016$23.68M-29.0%
2015Dec 31, 2015$33.36M–

More Viking Therapeutics figures

See a number that looks wrong?